(k) Provisions, Contingent liabilities and Contingent assets:
A provision is recognized when an enterprise has a present obligation as a result of past event; it is probable that an
outflow of resources will be required to settle the obligation, in respect of which a reliable estimate can be made.
Provisions are not discounted to its present value and are determined based on best estimate required to settle the
obligation at the balance sheet date. These are reviewed at each balance sheet date and adjusted to reflect the current
best estimates.
A contingent liability is a possible obligation that arises from past events whose existence will be confirmed by the
occurrence or non-occurrence of one or more uncertain future events beyond the control of the company or a present
obligation that is not recognized because it is not probable that an outflow of resources will be required to settle the
obligation.
Contingent assets are neither recognized nor disclosed in the financial statements.
(l) Cash & Cash Equivalents:
Cash and cash equivalents in the balance sheet comprise cash at bank and in hand and short-term investments with an
original maturity of three months or less.
(m) Cash Flow Statements:
Cash flows are reported using the indirect method, whereby profit before tax is adjusted for the effects of transactions of
a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments and item of income or
Expenses associated with investing or financing cash flows. The cash flows from operating, investing and financing
activities of the Company are segregated.
(n) Employee Benefits:
The company has not valued its obligation related to Gratuity as on March 31, 2024 hence no provision has made for
the same in the financial statements as on March 31, 2024.
(o) Segment Reporting:
The Company is primarily engaged in the Pharmaceutical Manufacturing, which in the context of AS 117 on
“Operating Segments” constitutes a single reporting segment. Further, there are no reportable geographical
segments.
2. Additional regulatory information:
(a) Details of crypto currency or virtual currency
The Company has neither traded nor invested in Crypto currency or Virtual Currency for the year ended on March 31,
2026 & March 31, 2025. Further, the Company has also not received any deposits or advances from any person for the
purpose of trading or investing in Crypto Currency or Virtual Currency.
(b) Compliance with approved scheme of arrangements
Company is not engaged in any scheme of arrangements.
(c) Undisclosed income
During the year ended on March 31, 2026 & March 31, 2025., the Company has not surrendered or disclosed as
income any transactions not recorded in the books of accounts in the course of tax assessments under the Income Tax
Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).
(d) Relationship with struck off companies
The Company does not have any transactions with the companies struck off under section 248 of the Companies Act,
2013 or section 560 of the Companies Act, 1956 during the year ended on March 31, 2026 & March 31, 2025.
(e) Compliance with numbers of layers of companies
The Company is in compliance with the number of layers of companies in accordance with clause 87 of Section 2 of
the Act read with the Companies (Restriction on number of Layers) Rules, 2017 during the year ended on March 31,
2026 & March 31, 2025.
(f) Utilisation of borrowed funds and share premium
During the year ended on March 31, 2026 & March 31, 2025, the Company has not advanced or Loans or invested
funds (either borrowed funds or share premium or kind of funds) to any other person(s) or entity(ies), including foreign
entities (Intermediaries) with the understanding (whether recorded in writing or otherwise) that the Intermediary shall:
i) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Company (Ultimate Beneficiaries) or
ii) provide any guarantee, security or the like to or on behalf of the ultimate beneficiaries.
During the year ended on March 31, 2025, March 31, 2024, the Company has not received any fund from any
person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing
or otherwise) that the Company shall:
j) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or
ii) provide any guarantee, security, or the like on behalf of the ultimate beneficiaries.
(g) The Company has not been declared Wilful Defaulter by any bank or financial institution or government or any
government authority.
(h) No proceeding have been initiated nor pending against the company for holding any benami property under the
Benami Transactions (Prohibition) Act,1988 (45 of 1988) and rules made thereunder.
(i) The Company has not revalued its tangible & intangible assets in the year ended March 31, 2026 & March 31, 2025.
(j) The Company does not have any intangible assets under development as on March 31, 2026 & March 31, 2025
(k) The Company does not have any Immovable Property whose title deeds are not registered in the name of
company.
(l) The Company has not been sanctioned working capital limits at any points of time during the year, from
banks or financial institutions on the basis of security of current assets
(m) The Company has not granted any loans & Advances to Promoters, directors, KMPs and related parties
during the reporting period.
3. Details of dues to Micro and Small Enterprises as defined under the MSMED Act, 2006:
Based on the information available with the Company in respect of MSME (as defined in the Micro, Small and Medium
Enterprises Development Act, 2006) and as confirmed to us there are no delays in payment of dues to such enterprise during
the year.
|